TY  - GEN
AU  - Reichardt,Peter
AU  - Schlemmer,Marcus
AU  - Delgado Perez,Juan R
AU  - Papai,Zsuzsanna
AU  - Prausova,Jana
AU  - Melichar,Bohuslav
AU  - Fumagalli,Elena
AU  - Barone,Carlo
AU  - Bauer,Sebastian
AU  - Pustowka,Anette
AU  - Crippa,Stefania
AU  - Castellana,Ramon
AU  - Quiering,Claudia
AU  - Le Cesne,Axel
TI  - Safety of Imatinib Mesylate in a Multicenter Expanded Access Program in Adult Patients with Gastrointestinal Stromal Tumors in the Adjuvant Setting
SN  - 2296-5262
PY  - 2020///0413
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Chemotherapy, Adjuvant
KW  - Female
KW  - Gastrointestinal Neoplasms
KW  - drug therapy
KW  - Gastrointestinal Stromal Tumors
KW  - Humans
KW  - Imatinib Mesylate
KW  - administration & dosage
KW  - Male
KW  - Middle Aged
KW  - Protein Kinase Inhibitors
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study
UR  - https://doi.org/10.1159/000502749
ER  -